NCT03049059View on ClinicalTrials.gov

A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

December 1, 2016

Study Completion Date

February 1, 2017

Conditions
Picoseconds LaserMelasma
Interventions
DEVICE

Fractional Picosecond 1,064 nm laser

Fractional Picosecond 1,064 nm laser and daily application with 4% hydroquinone cream

DRUG

4% hydroquinone cream

All Listed Sponsors
lead

Mae Fah Luang University Hospital

OTHER

NCT03049059 - A Comparative Study for Efficacy and Safety Between 4% Hydroquinone Cream With or Without Fractional Picosecond 1,064 nm Laser for the Treatment of Dermal or Mixed Type Melasma | Biotech Hunter | Biotech Hunter